EUVIMEDEUVIMED entdecken
Crossref

IFN ‐ I ‐Mediated Transcriptional Reprogramming Drives Myeloid‐Skewed Hematopoiesis in Sickle Cell Anemia

Marion Serra, Steven Akkaya, Marine Aglave, Mohammad Salma iD, Sara Bencheikh, Patricia Hermand, Carine Lefevre, Romain Duval, Jade Merrer, Fallou Leye, Joelle Magne, Isabelle Plo und 4 weitere

American Journal of Hematology · 2026-06 · 101 (6) · 1283-1301

DOI: 10.1002/ajh.70277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 19.03.2026. Verfasst von Marion Serra und 15 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Université des Antilles, INSERM, EFS, BIGR U1134, Laboratory of Blood Group Antigens, Hematopoiesis and Sickle Cell Disease, P…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Interferon Type I, Myelopoiesis, Hematopoiesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Etablissement Français du Sang, European Hematology Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophils and monocytes are persistently elevated in sickle cell anemia (SCA), yet the intrinsic mechanisms driving pathological myelopoiesis and inflammation remain poorly defined. Through single‐cell RNA sequencing and functional assays, we demonstrate that hematopoietic stem and multipotent progenitor cells (HSPCs) in SCA are transcriptionally reprogrammed toward myeloid differentiation. This process is orchestrated by aberrant activation of Type I interferon (IFN‐I) signaling, which promotes premature myeloid commitment of hematopoietic stem cells. SCA progenitors further exhibit unexpected responsiveness to granulocyte colony‐stimulating factor (G‐CSF) through upregulation of CSF3R, resulting in skewed myelopoiesis toward the monocytic lineage. Importantly, hydroxyurea treatment attenuates IFN‐I signaling in neutrophils, consistent with its therapeutic role in reducing excessive inflammation and granulopoiesis. Collectively, these findings uncover IFN‐I–driven remodeling of hematopoiesis as a fundamental mechanism of leukocytosis and chronic inflammation in SCA, and establish a tractable therapeutic axis to mitigate innate immunity activation in this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellInterferon Type IMyelopoiesisHematopoiesisTranscription, GeneticCellular ReprogrammingHumansHydroxyureaHematopoietic Stem CellsNeutrophilsSignal TransductionGranulocyte Colony-Stimulating FactorMonocytesMyeloid CellsInflammation

Substanzen

Interferon Type IHydroxyureaGranulocyte Colony-Stimulating Factor

Autor:innen und Institutionen

  • Université Paris Cité, Université des Antilles, INSERM, EFS, BIGR U1134, Laboratory of Blood Group Antigens, Hematopoiesis and Sickle Cell Disease, Paris, France.
  • Gustave Roussy, Plateforme de Bioinformatique, Villejuif, France.
  • IGMM, Univ Montpellier, CNRS, Montpellier, France.
  • Centre National de Référence Pour Les Groupes Sanguins, Établissement Français du Sang (EFS), Paris, France.
  • Unité d'Epidémiologie Clinique, INSERM CIC 1426, AP-HP, Hôpital Robert Debré, Paris, France.
  • Université Paris Cité, ECEVE, UMR 1123, Inserm, Paris, France.

ORCID-Profile: Mohammad Salma, Slim Azouzi, Berengere Koehl

Förderung

  • Agence Nationale de la Recherche
  • Etablissement Français du Sang
  • European Hematology Association
  • Sickle Cell Disease Center at Robert Debré Hospital

Zitieren

APA

Serra, M., Akkaya, S., Aglave, M., Salma, M., Bencheikh, S., Hermand, P., Lefevre, C., Duval, R., Merrer, J., Leye, F., Magne, J., Plo, I., Blanc, L., Soler, E., Azouzi, S., & Koehl, B. (2026). IFN ‐ I ‐Mediated Transcriptional Reprogramming Drives Myeloid‐Skewed Hematopoiesis in Sickle Cell Anemia. American Journal of Hematology, 101(6), 1283-1301. https://doi.org/10.1002/ajh.70277

Vancouver

Serra M, Akkaya S, Aglave M, Salma M, Bencheikh S, Hermand P, et al. IFN ‐ I ‐Mediated Transcriptional Reprogramming Drives Myeloid‐Skewed Hematopoiesis in Sickle Cell Anemia. American Journal of Hematology. 2026;101(6):1283-1301. doi:10.1002/ajh.70277

BibTeX
@article{Serra2026,
  author = {Serra, Marion and Akkaya, Steven and Aglave, Marine and Salma, Mohammad and Bencheikh, Sara and Hermand, Patricia and Lefevre, Carine and Duval, Romain and Merrer, Jade and Leye, Fallou and Magne, Joelle and Plo, Isabelle and Blanc, Lionel and Soler, Eric and Azouzi, Slim and Koehl, Berengere},
  title = {IFN ‐ I ‐Mediated Transcriptional Reprogramming Drives Myeloid‐Skewed Hematopoiesis in Sickle Cell Anemia},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {6},
  pages = {1283--1301},
  doi = {10.1002/ajh.70277}
}
Kostenlos starten →